0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

The Th1/Th2 Paradigm in Guillain-Barré Syndrome

Hong-Liang Zhang, MD; Hai-Feng Li, MD, PhD
Arch Neurol. 2011;68(9):1209-1210. doi:10.1001/archneurol.2011.214.
Text Size: A A A
Published online

Extract

Nyati and colleagues1 described a cohort of 65 patients with Guillain-Barré syndrome (GBS) with characteristic lymphocyte cytokine expression profiles in response to Campylobacter jejuni outer membrane protein stimulation. While their findings followed the T helper (Th) 1/Th2 paradigm, they should be interpreted with caution before robust conclusions are drawn.

Guillain-Barré syndrome is a heterogeneous disease entity with several clinical subtypes including acute inflammatory demyelinating polyneuropathy (AIDP) and the axonal variants.2 The latter is closely associated with C jejuni infection.3 Given the different etiologies and clinical features, we would like to know if the authors performed stratified analyses, eg, AIDP vs axonal variants. Although an association between C jejuni infection and AIDP has been proposed, we wonder whether the characteristic responses of lymphocytes are antigen specific. Unless they can provide more evidence, eg, C jejuni–specific antibodies or GM1 antibodies supporting an overwhelming ratio of C jejuni infection in the studied cohort, further stratified analysis seems a necessity.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

September 1, 2011
Kishan K. Nyati, MSc; Avantika Verma, MSc; Kashi N. Prasad, MD
Arch Neurol. 2011;68(9):1209-1210. doi:10.1001/archneurol.2011.215.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

103 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();